<!DOCTYPE html>
<html lang="zh">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Albumin Nanocages with Methotrexate and Chondroitin Sulfate as a DualpH/GSH-Responsive Tumor Targeting Nanomedicine for Synergistic Cancer Therapy -PMC</title>
  <style>
    body {
      font-family: "Helvetica Neue", "Noto Sans TC", sans-serif;
      max-width: 720px;
      margin: 2em auto;
      padding: 0 1em;
      color: #333;
      line-height: 1.8;
      background: #fff;
    }
    h1, h2, h3 {
      text-align: center;
      color: #222;
    }
    .lang-switcher {
      text-align: center;
      margin-bottom: 2em;
    }
    .lang-btn {
      margin: 0 0.5em;
      padding: 0.4em 1em;
      border: none;
      background-color: #eee;
      border-radius: 4px;
      cursor: pointer;
      font-weight: bold;
    }
    .lang-btn.active {
      background-color: #007acc;
      color: white;
    }
    ul {
      padding-left: 1.2em;
    }
    a {
      color: #007acc;
      text-decoration: none;
    }
    a:hover {
      text-decoration: underline;
    }
    img {
      max-width: 100%;
      height: auto;
    }
    .share-block {
      text-align: center;
      margin: 1em 0 2em;
      font-size: 0.95em;
    }
    .share-block a svg {
      width: 24px;
      height: 24px;
      display: inline-block;
      vertical-align: middle;
      margin: 0 0.4em;
      transition: transform 0.2s ease;
      cursor: pointer;
    }
    .share-block a svg:hover {
      transform: scale(1.2);
    }
  </style>

</head>
<body>
  <h1>Albumin Nanocages with Methotrexate and Chondroitin Sulfate as a DualpH/GSH-Responsive Tumor Targeting Nanomedicine for Synergistic Cancer Therapy -PMC</h1>
  
  <div class="share-block">
    <span>üîó ÂàÜ‰∫´ÈÄôÁØáÊëòË¶ÅÔºö</span>
    <a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fbreastcancer-tech.github.io%2Fbreast-cancer-1%2Farticles%2Falbumin-nanocages-with-methotrexate-and-chondroitin-sulfate-as-a-dualphgshresponsive-tumor-targeting-nanomedicine-for-synergistic-cancer-therapy-pmc-summary.html" target="_blank" title="Facebook">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--!Font Awesome Free 6.7.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2025 Fonticons, Inc.--><path d="M512 256C512 114.6 397.4 0 256 0S0 114.6 0 256C0 376 82.7 476.8 194.2 504.5V334.2H141.4V256h52.8V222.3c0-87.1 39.4-127.5 125-127.5c16.2 0 44.2 3.2 55.7 6.4V172c-6-.6-16.5-1-29.6-1c-42 0-58.2 15.9-58.2 57.2V256h83.6l-14.4 78.2H287V510.1C413.8 494.8 512 386.9 512 256h0z"/></svg>
    </a>
    <a href="https://x.com/intent/tweet?url=https%3A%2F%2Fbreastcancer-tech.github.io%2Fbreast-cancer-1%2Farticles%2Falbumin-nanocages-with-methotrexate-and-chondroitin-sulfate-as-a-dualphgshresponsive-tumor-targeting-nanomedicine-for-synergistic-cancer-therapy-pmc-summary.html&text=Albumin%20Nanocages%20with%20Methotrexate%20and%20Chondroitin%20Sulfate%20as%20a%20DualpH%2FGSH-Responsive%20Tumor%20Targeting%20Nanomedicine%20for%20Synergistic%20Cancer%20Therapy%20-PMC" target="_blank" title="X">
      <svg xmlns="http://www.w3.org/2000/svg" x="0px" y="0px" width="100" height="100" viewBox="0 0 50 50">
<path d="M 11 4 C 7.134 4 4 7.134 4 11 L 4 39 C 4 42.866 7.134 46 11 46 L 39 46 C 42.866 46 46 42.866 46 39 L 46 11 C 46 7.134 42.866 4 39 4 L 11 4 z M 13.085938 13 L 21.023438 13 L 26.660156 21.009766 L 33.5 13 L 36 13 L 27.789062 22.613281 L 37.914062 37 L 29.978516 37 L 23.4375 27.707031 L 15.5 37 L 13 37 L 22.308594 26.103516 L 13.085938 13 z M 16.914062 15 L 31.021484 35 L 34.085938 35 L 19.978516 15 L 16.914062 15 z"></path></svg>
    </a>
    <a href="https://www.threads.net/intent/post?url=https%3A%2F%2Fbreastcancer-tech.github.io%2Fbreast-cancer-1%2Farticles%2Falbumin-nanocages-with-methotrexate-and-chondroitin-sulfate-as-a-dualphgshresponsive-tumor-targeting-nanomedicine-for-synergistic-cancer-therapy-pmc-summary.html&text=Albumin%20Nanocages%20with%20Methotrexate%20and%20Chondroitin%20Sulfate%20as%20a%20DualpH%2FGSH-Responsive%20Tumor%20Targeting%20Nanomedicine%20for%20Synergistic%20Cancer%20Therapy%20-PMC" target="_blank" title="Threads">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 448 512"><!--!Font Awesome Free 6.7.2 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2025 Fonticons, Inc.--><path d="M64 32C28.7 32 0 60.7 0 96V416c0 35.3 28.7 64 64 64H384c35.3 0 64-28.7 64-64V96c0-35.3-28.7-64-64-64H64zM294.2 244.3c19.5 9.3 33.7 23.5 41.2 40.9c10.4 24.3 11.4 63.9-20.2 95.4c-24.2 24.1-53.5 35-95.1 35.3h-.2c-46.8-.3-82.8-16.1-106.9-46.8C91.5 341.8 80.4 303.7 80 256v-.1-.1c.4-47.7 11.5-85.7 33-113.1c24.2-30.7 60.2-46.5 106.9-46.8h.2c46.9 .3 83.3 16 108.2 46.6c12.3 15.1 21.3 33.3 27 54.4l-26.9 7.2c-4.7-17.2-11.9-31.9-21.4-43.6c-19.4-23.9-48.7-36.1-87-36.4c-38 .3-66.8 12.5-85.5 36.2c-17.5 22.3-26.6 54.4-26.9 95.5c.3 41.1 9.4 73.3 26.9 95.5c18.7 23.8 47.4 36 85.5 36.2c34.3-.3 56.9-8.4 75.8-27.3c21.5-21.5 21.1-47.9 14.2-64c-4-9.4-11.4-17.3-21.3-23.3c-2.4 18-7.9 32.2-16.5 43.2c-11.4 14.5-27.7 22.4-48.4 23.5c-15.7 .9-30.8-2.9-42.6-10.7c-13.9-9.2-22-23.2-22.9-39.5c-1.7-32.2 23.8-55.3 63.5-57.6c14.1-.8 27.3-.2 39.5 1.9c-1.6-9.9-4.9-17.7-9.8-23.4c-6.7-7.8-17.1-11.8-30.8-11.9h-.4c-11 0-26 3.1-35.6 17.6l-23-15.8c12.8-19.4 33.6-30.1 58.5-30.1h.6c41.8 .3 66.6 26.3 69.1 71.8c1.4 .6 2.8 1.2 4.2 1.9l.1 .5zm-71.8 67.5c17-.9 36.4-7.6 39.7-48.8c-8.8-1.9-18.6-2.9-29-2.9c-3.2 0-6.4 .1-9.6 .3c-28.6 1.6-38.1 15.5-37.4 27.9c.9 16.7 19 24.5 36.4 23.6l-.1-.1z"/></svg>
    </a>
  </div>

  <div style="text-align: center;"><img src="https://i.imgur.com/H4JFuyI.png" alt="News Cover Image" style="max-width: 100%; height: auto; border-radius: 12px; margin-bottom: 1.5em;"></div>
  <div class="lang-switcher">
    <button class="lang-btn active" data-lang="zh">‰∏≠Êñá</button><button class="lang-btn " data-lang="en">English</button><button class="lang-btn " data-lang="jp">Êó•Êú¨Ë™û</button>
  </div>
  
  <div class="ads-block" style="margin: 2.5em 0; position: relative; text-align: center;">
    <a href="https://cancerfree.io/" target="_blank" style="display: inline-block; position: relative;">
      <img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQI9CDgh7JwzUGH4QTfT5Su2MGI3gUURdf3Tw&s" alt="Advertisement" style="width: 100%; border-radius: 12px; box-shadow: 0 2px 6px rgba(0,0,0,0.1);">
      <div style="
        position: absolute;
        top: 8px;
        right: 8px;
        background: rgba(0, 0, 0, 0.6);
        color: white;
        font-size: 0.75rem;
        padding: 2px 6px;
        border-radius: 4px;
        font-weight: bold;
        letter-spacing: 0.5px;
      ">
        Âª£Âëä
      </div>
    </a>
  </div>
  
  <div class="lang-content" data-lang="zh" style="">Okay, here's a breakdown of the information extracted from the provided text, organized for clarity.  I'm focusing on the key points related to the research and the materials cited.

**1. Core Research Focus:**

*   **Topic:** The research explores the use of albumin-based nanoparticles for targeted cancer diagnosis and therapy, particularly focusing on breast cancer.
*   **Key Approach:** Utilizing albumin (a naturally occurring protein) to create nanoparticles that can deliver drugs, imaging agents, or therapeutic payloads directly to cancer cells.
*   **Specific Focus Areas:**
    *   **Ferroptosis Manipulation:**  Some research aims to bidirectionally manipulate ferroptosis (a form of cell death) in tumor cells and CD8 T cells.
    *   **Size-Dependent Effects:**  Investigating how the size of albumin-templated platinum sulfide nanodots affects their therapeutic and diagnostic properties.
    *   **Ex Vivo Drug Loading:**  Developing methods to load albumin-drug conjugates outside the body (ex vivo) to enhance drug delivery.

**2. Key Research Papers & Citations (with brief summaries):**

Here's a list of the cited papers, extracted and summarized.  I'm including the DOI where available, as that's a stable link to the paper.

*   **Richardson et al. (1994):**  Describes the cell cycle stage specificity of methotrexate's blocking effect on cancer cells. (DOI: 10.1159/000133682)
*   **Larsen et al. (2016):**  Provides an overview of albumin-based drug delivery systems and their potential to cure diseases. (DOI: 10.1186/s4059101600488)
*   **Tan & Ho (2018):** Discusses how to navigate albumin-based nanoparticles through different drug delivery routes. (DOI: 10.1016/j.drudis.2018.01.051)
*   **Liu et al. (2020):**  Details a method for controlled loading of albumin-drug conjugates *ex vivo* to improve drug delivery and antitumor efficacy. (DOI: 10.1016/j.jconrel.2020.08.015)
*   **Wang et al. (2017):**  Reports on an antitumor study using chondroitin sulfate-methotrexate nanogels. (DOI: 10.1186/s1167101723241)
*   **Yang et al. (2025):** Explores albumin nanoassembly to bidirectionally manipulate ferroptosis in tumor and CD8 T cells for triple-negative breast cancer therapy. (DOI: 10.1016/j.ajps.2024.100970)
*   **Li et al. (2023):** Describes albumin-templated platinum sulfide nanodots for size-dependent cancer theranostics. (DOI: 10.1016/j.actbio.2022.10.057)
*   **Wang et al. (2023):** Details albumin-based nanodevices for breast cancer diagnosis and therapy.
*   **Mohanty et al. (2015):** Discusses controlled loading of albumin-drug conjugates ex vivo for enhanced drug delivery and antitumor efficacy. (DOI: 10.1016/j.jconrel.2020.08.015)

**3. Data Availability:**

*   All data generated during the study are presented in the manuscript and supplementary materials.

**4. Supplementary Materials:**

*   Supplementary 1: Materials and Methods
*   Figures S1 to S23
*   Tables S1 to S3
*   bmr.0245.f0245.docx (likely a data file or supplementary document)

**5. Key Terms & Concepts:**

*   **Albumin:** The protein used as the base for nanoparticle construction.
*   **Nanoparticles:** Tiny particles used for targeted drug delivery.
*   **Breast Cancer:** The primary disease target.
*   **Ferroptosis:** A form of cell death.
*   **Ex Vivo:**  Outside the body.
*   **Theranostics:** Combining diagnostics and therapeutics.
*   **Methotrexate:** A chemotherapy drug.
*   **Chondroitin Sulfate:** A type of glycosaminoglycan.
*   **Platinum Sulfide:** A material used in nanodots.



Let me know if you'd like me to elaborate on any of these points or extract specific information!</div><div class="lang-content" data-lang="en" style="display: none;">Okay, here's a breakdown of the information extracted from the provided text, organized into categories.  I'm focusing on the key details about the research and the materials used.

**1. Overall Research Focus & Context**

*   **Topic:** The research focuses on albumin-based nanoparticles for drug delivery, particularly in the context of breast cancer diagnosis and therapy. It explores various approaches, including manipulating ferroptosis (a form of cell death) and utilizing platinum sulfide nanodots.
*   **Goal:** To enhance drug delivery, improve therapeutic efficacy, and potentially enable theranostics (combining diagnosis and therapy).
*   **Recent Developments:** The research highlights recent advancements in albumin-based nanoparticle technology, including controlled loading of drug conjugates and size-dependent theranostics.

**2. Materials & Nanoparticle Components**

*   **Primary Material:** Albumin (human serum albumin - HSA) is the core building block for the nanoparticles.
*   **Drug Conjugates:** Albumin is used to conjugate (attach) drugs, allowing for controlled release and targeted delivery.
*   **Platinum Sulfide Nanodots:** These are used for size-dependent theranostics, where the size of the nanodots influences their therapeutic effect.
*   **Methotrexate (MTX):** A chemotherapeutic drug frequently incorporated into the nanoparticles.
*   **Platinum:** Used in the form of platinum sulfide nanodots.
*   **Polyamidoamine and Oligoethylene Glycols Dendrons:** Used to prepare methotrexate nanoparticles.
*   **Chondroitin Sulfate:** Used in combination with methotrexate to form nanogels.

**3. Therapeutic Approaches & Mechanisms**

*   **Ferroptosis Manipulation:**  Nanoparticles are designed to bidirectionally manipulate ferroptosis, inducing it in tumor cells while protecting healthy CD8 T cells.
*   **Cell Cycle Specificity:** Methotrexate's ability to block the cell cycle is explored.
*   **Size-Dependent Effects:** The size of platinum sulfide nanodots is exploited to achieve different therapeutic outcomes.

**4. Key Research Groups & Contributors (Based on Names)**

*   **Yang T, Liu Z, Fu Z, Zhang X, Cao Y, Liang Q, Miao J, Yang H, Zhang T, Hei J:** Involved in manipulating ferroptosis.
*   **Wang Y, Iqbal H, UrRehman U, Zhai L, Yuan Z, Razzaq A, Lv M, Wei H, Ning X, Xin J:** Focused on albumin-based nanodevices for breast cancer.
*   **Li M, Wang Y, Li T, Zhang J, Wang X, Luo J, You M, Yang T, Deng Y, Yang H:** Developed albumin-templated platinum sulfide nanodots.
*   **Richardson VB, Littlefield LG, Sayer AM, Peterson PT:** Studied the cell cycle specificity of methotrexate.

**5. Data & Availability**

*   **Data Availability:** All data generated during the study are presented in the manuscript and supplementary materials.
*   **Supplementary Materials:** Include Materials and Methods, Figures S1-S23, and Tables S1-S3.

**6. Relevant Journals**

*   *Journal of Controlled Release*
*   *Acta Biomaterialia*
*   *Asian Journal of Pharmaceutical Sciences*
*   *Cytogenetics and Cell Genetics*
*   *Molecular Cell Therapy*
*   *Drug Discovery Today*
*   *Nanoscale Research Letters*
*   *Scientific Reports*



Let me know if you're interested in a more detailed breakdown of any specific aspect of this research!</div><div class="lang-content" data-lang="jp" style="display: none;">Okay, here's a breakdown of the information extracted from the provided text, organized for clarity.  I'm focusing on the key details about the research and the materials cited.

**1. Core Research Focus & Summary**

*   **Overall Theme:** The text is a collection of citations and references related to albumin-based nanoparticles for drug delivery, particularly in the context of cancer therapy. It highlights the versatility of albumin as a platform for creating targeted and effective nanodevices.
*   **Specific Areas of Investigation:**
    *   **Breast Cancer:** A significant portion of the research focuses on using albumin nanoparticles for diagnosis and therapy of breast cancer, including triple-negative breast cancer.
    *   **Drug Delivery Routes:**  Studies explore various routes for administering albumin-based nanoparticles.
    *   **Theranostics:** Combining therapeutic and diagnostic capabilities within the nanoparticles.
    *   **Ferroptosis:**  Some research investigates manipulating ferroptosis (a form of cell death) in tumor cells using albumin nanoparticles.
    *   **Platinum Sulfide Nanodots:**  Studies using albumin-templated platinum sulfide nanodots for cancer theranostics.

**2. Key Materials & Techniques Mentioned**

*   **Albumin:** The central material ‚Äì used as a platform for nanoparticle construction.
*   **Methotrexate (MTX):** A chemotherapy drug frequently incorporated into the nanoparticles.
*   **Platinum Sulfide Nanodots:**  Nanoparticles composed of platinum sulfide, formed using albumin as a template.
*   **Chondroitin Sulfate:** Used in conjunction with methotrexate to form nanogels.
*   **Dendrimers:** Used to prepare methotrexate nanoparticles.
*   **Ferroptosis Inducers:** Substances used to induce ferroptosis in cancer cells.
*   **X-ray induced chromosome damage:** Used to resolve cell cycle specificity of methotrexate.

**3. Citations & References (Summarized)**

Here's a summary of the cited works, grouped by their main contribution.  I'm including the volume/issue/page numbers where available.

*   **Albumin as a Drug Delivery Platform (General):**
    *   Larsen et al. (2016):  "Albumin-based drug delivery Harnessing nature to cure disease." (Mol Cell Ther, 4:3) - A broad overview of the field.
    *   Tan & Ho (2018): "Navigating albumin-based nanoparticles through various drug delivery routes." (Drug Discov Today, 23(5): 1108-1114) - Focuses on delivery routes.
    *   Wang et al. (2023): "Albuminbased nanodevices for breast cancer diagnosis and therapy." (J Drug Deliv Sci Technol, 79: 104072) - Specific to breast cancer.
    *   Liu et al. (2020): "Controlled loading of albumindrug conjugates ex vivo for enhanced drug delivery and antitumor efficacy." (J Control Release, 328: 112) - Focuses on *ex vivo* loading.
    *   Yang et al. (2025): "Albumin nanoassembly bidirectionally manipulated ferroptosis in tumor and CD8 T cells for triplenegative breast cancer therapy." (Asian J Pharm Sci, 20: 100970) - Focuses on ferroptosis.
*   **Methotrexate-Related Studies:**
    *   Richardson et al. (1994): Cell cycle specificity of methotrexate. (Cytogenet Cell Genet, 66(1): 126-128)
    *   Wang et al. (2017): Antitumor study of chondroitin sulfatemethotrexate nanogels. (Nanoscale Res Lett, 12: 572)
    *   Zhao et al. (2016): Methotrexate nanoparticles prepared with codendrimer. (Sci Rep, 6: 28983)
*   **Other Specific Studies:**
    *   Li et al. (2023): Albumin-templated platinum sulfide nanodots. (Acta Biomater, 155: 564-574)

**4. Data Availability**

*   All data generated during the study are presented in the manuscript and supplementary materials.

**5. Supplementary Materials**

*   Supplementary 1: Materials and Methods
*   Figs. S1 to S23
*   Tables S1 to S3
*   bmr.0245.f0245.docx (likely a data file)

**Important Notes:**

*   This is a compilation of references, not a single research paper.
*   The text is heavily reliant on citations, so it's a summary of *other* research.
*   The "bmr.0245.f0245.docx" file is likely a data file associated with one of the cited studies.



If you have any specific questions about a particular citation or aspect of the research, feel free to ask!</div>
  <p style="text-align:center; margin-top: 2em;">
    <a href="./albumin-nanocages-with-methotrexate-and-chondroitin-sulfate-as-a-dualphgshresponsive-tumor-targeting-nanomedicine-for-synergistic-cancer-therapy-pmc-seo.html">üëâ Êü•ÁúãÂéüÊñá / Full Article</a>
  </p>
  <script>
    document.querySelectorAll('.lang-btn').forEach(btn => {
      btn.addEventListener('click', () => {
        const lang = btn.dataset.lang;
        document.querySelectorAll('.lang-btn').forEach(b => b.classList.remove('active'));
        btn.classList.add('active');
        document.querySelectorAll('.lang-content').forEach(div => {
          div.style.display = div.dataset.lang === lang ? '' : 'none';
        });
      });
    });
  </script>
</body>
</html>